CA3085488C - Formulation analgesique transdermique - Google Patents

Formulation analgesique transdermique

Info

Publication number
CA3085488C
CA3085488C CA3085488A CA3085488A CA3085488C CA 3085488 C CA3085488 C CA 3085488C CA 3085488 A CA3085488 A CA 3085488A CA 3085488 A CA3085488 A CA 3085488A CA 3085488 C CA3085488 C CA 3085488C
Authority
CA
Canada
Prior art keywords
none
ethanol
ketoprofen
ethoh
cineole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3085488A
Other languages
English (en)
Other versions
CA3085488A1 (fr
Inventor
Paul Mills
Nana SATAKE
Original Assignee
Meat and Livestock Autralia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meat and Livestock Autralia Ltd filed Critical Meat and Livestock Autralia Ltd
Priority claimed from PCT/AU2018/000255 external-priority patent/WO2019113625A1/fr
Publication of CA3085488A1 publication Critical patent/CA3085488A1/fr
Application granted granted Critical
Publication of CA3085488C publication Critical patent/CA3085488C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne une formulation liquide transdermique qui comprend un agent anti-inflammatoire non stéroïdien à base d'acide propionique, tel que du kétoprofène, et un activateur de pénétration dermique contenant un alcool, un émollient et une huile essentielle. L'invention concerne également des méthodes d'utilisation et de préparation de la formulation liquide transdermique susmentionnée.
CA3085488A 2017-12-11 2018-12-11 Formulation analgesique transdermique Active CA3085488C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2017904975 2017-12-11
AU2017904975A AU2017904975A0 (en) 2017-12-11 Transdermal analgesic formulation
PCT/AU2018/000255 WO2019113625A1 (fr) 2017-12-11 2018-12-11 Formulation analgésique transdermique

Publications (2)

Publication Number Publication Date
CA3085488A1 CA3085488A1 (fr) 2019-06-20
CA3085488C true CA3085488C (fr) 2026-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
Keeble et al. Hydrogen peroxide is a novel mediator of inflammatory hyperalgesia, acting via transient receptor potential vanilloid 1-dependent and independent mechanisms
Smith et al. Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats
Hussain et al. Equivalent analgesic effectiveness between perineural and intravenous dexamethasone as adjuvants for peripheral nerve blockade: a systematic review and meta-analysis
Chen et al. The use of the antimicrobial peptide piscidin (PCD)-1 as a novel anti-nociceptive agent
US20250213512A1 (en) Transdermal analgesic formulation
Chaves Filho et al. Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: a promising drug repurposing for bipolar disorder treatment?
Spofford et al. Ketoprofen produces modality-specific inhibition of pain behaviors in rats after plantar incision
De Souza et al. Antiallodynic effect and side effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer: comparison with ω-conotoxin MVIIA and morphine
Laila et al. Wound healing effect of Haruan (Channa striatus) spray
Jiang et al. Acetyl-11-keto-β-boswellic acid extracted from Boswellia serrata promotes Schwann cell proliferation and sciatic nerve function recovery
Yaw et al. Pharmacokinetic properties of a single administration of oral gabapentin in the great horned owl (Bubo virginianus)
Garrone et al. Paracetamol (acetaminophen) rescues cognitive decline, neuroinflammation and cytoskeletal alterations in a model of post-operative cognitive decline (POCD) in middle-aged rats
Van Genechten et al. Autologous protein solution as selective treatment for advanced patellofemoral osteoarthritis in the middle-aged female patient: 54% response rate at 1 year follow-up
Guo et al. Mechanism of Gastrodin against neurotoxicity based on network pharmacology, molecular docking and experimental verification
CA3085488C (fr) Formulation analgesique transdermique
Paull et al. Effect of local infusion of NSAID analgesics administered alone or in combination on the pain associated with band castration in calves
Abshenas et al. Chemical sterilization by intratesticular injection of eugenia caryophyllata essential oil in dog: a histopathological study
George et al. Locally mediated analgesic effect of bradykinin type 2 receptor antagonist HOE 140 during acute inflammatory pain in rats
Kadar et al. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model
do Nascimento et al. Pain assessment and acute phase response in donkeys submitted to inguinal orchiectomy
Pugh et al. Plasma concentration of meloxicam in pediatric rats.
Heniff et al. Pharmacokinetics of a single dose of flunixin transdermal formulation in American bullfrogs (Lithobates catesbeianus)
Barbarossa et al. Pharmacokinetics of buprenorphine following constant rate infusion for postoperative analgesia in dogs undergoing ovariectomy
US12138251B2 (en) Fibrosis drug
Olagbende-Dada Effects of the bluish liquid (hemolymph) from the African giant snail (Achatina marginata) on the blood coagulation time and erythropoietic volume